March 12, 2019

After years of continued struggle with Hepatitis C, a new product becomes commercially available. Hepatitis C is no longer the leading cause of death in adult hemophiliacs in the US. The new product is hailed as a cure for Hepatitis C.

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.